Diabetes, Vol 46, Issue 12 1975-1982, Copyright © 1997 by American Diabetes Association

ARTICLES

Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens

M Cetkovic-Cvrlje, IC Gerling, A Muir, MA Atkinson, JF Elliot and EH Leiter
The Jackson Laboratory, Bar Harbor, Maine 04609, USA.

A single injection of syngeneic islet cells into the thymus of 4-week-old NOD/Lt female mice strongly retards diabetogenesis. The present study used the intrathymic route of antigen administration to compare the relative efficacy of peptides/proteins derived from two major candidate pancreatic beta-cell autoantigens, insulin and GAD65, to modulate diabetogenesis. Intrathymic administration of insulin B chain or recombinant human GAD65 significantly suppressed diabetogenesis during a 20-week follow-up period, whereas no protection was mediated by either insulin A chain or a synthetic peptide (A2) derived from it. Quite unexpectedly, two GAD65-derived peptides near the COOH-terminus (p34 and p35) accelerated diabetes onset. Semiquantitative reverse transcription-polymerase chain reaction analysis was performed on cDNAs from isolated islets or whole pancreases of NOD/Lt females 4 weeks after intrathymic injections. Protection mediated by intrathymic administration with either intact islet cells or GAD65 were correlated with an upregulation of mRNA for T-helper 2 (Th2)-associated cytokines (interleukin [IL]-4, IL-10), concomitant with downregulation of Th1-associated interferon (IFN) transcripts (all normalized to T-cell receptor Cbeta transcripts) in islet-infiltrating lymphocytes. Protection mediated by the intrathymic administration of insulin B chain, however, correlated only with a modest upregulation of IL-4 and IL-10 transcript levels, and no diminution in IFN-gamma transcripts. In contrast, the diabetes-accelerating GAD65 p34 and p35 peptides were not associated with an immune deviation, expressing levels of IFN-gamma characteristic of islet-infiltrating lymphocytes in vehicle-injected NOD controls. Hence, Th1-to-Th2 immune deviation provides only a partial explanation for peptide immunotherapy of diabetes in NOD mice. The finding that certain peptides can accelerate rather than retard diabetogenesis as a function of route and age of administration adds a cautionary note to this type of therapy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form J. Immunol., May 15, 2007; 178(10): 6051 - 6057. [Abstract] [Full Text] [PDF]

				G. Han, Y. Li, J. Wang, R. Wang, G. Chen, L. Song, R. Xu, M. Yu, X. Wu, J. Qian, et al. Active Tolerance Induction and Prevention of Autoimmune Diabetes by Immunogene Therapy Using Recombinant Adenoassociated Virus Expressing Glutamic Acid Decarboxylase 65 Peptide GAD500-585 J. Immunol., April 15, 2005; 174(8): 4516 - 4524. [Abstract] [Full Text] [PDF]

				H. Kojima, M. Fujimiya, K. Matsumura, T. Nakahara, M. Hara, and L. Chan Extrapancreatic insulin-producing cells in multiple organs in diabetes PNAS, February 24, 2004; 101(8): 2458 - 2463. [Abstract] [Full Text] [PDF]

				C. Chen, W.-H. Lee, P. Yun, P. Snow, and C.-P. Liu Induction of Autoantigen-Specific Th2 and Tr1 Regulatory T Cells and Modulation of Autoimmune Diabetes J. Immunol., July 15, 2003; 171(2): 733 - 744. [Abstract] [Full Text] [PDF]

				A. A. Chentoufi and C. Polychronakos Insulin Expression Levels in the Thymus Modulate Insulin-Specific Autoreactive T-Cell Tolerance: The Mechanism by Which the IDDM2 Locus May Predispose to Diabetes Diabetes, May 1, 2002; 51(5): 1383 - 1390. [Abstract] [Full Text] [PDF]

				M. Cetkovic-Cvrlje, B. A. Roers, B. Waurzyniak, X.-P. Liu, and F. M. Uckun Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice Blood, September 1, 2001; 98(5): 1607 - 1613. [Abstract] [Full Text] [PDF]

				S. S. Wilson, T. C. White, and D. DeLuca Therapeutic Alteration of Insulin-Dependent Diabetes Mellitus Progression by T Cell Tolerance to Glutamic Acid Decarboxylase 65 Peptides In Vitro and In Vivo J. Immunol., July 1, 2001; 167(1): 569 - 577. [Abstract] [Full Text] [PDF]

				B. J. Whalen, J. Marounek, P. Weiser, M. C. Appel, D. L. Greiner, J. P. Mordes, and A. A. Rossini BB Rat Thymocytes Cultured in the Presence of Islets Lose Their Ability to Transfer Autoimmune Diabetes Diabetes, May 1, 2001; 50(5): 972 - 979. [Abstract] [Full Text]

				A. Quinn, B. McInerney, E. P. Reich, O. Kim, K. P. Jensen, and E. E. Sercarz Regulatory and Effector CD4 T Cells in Nonobese Diabetic Mice Recognize Overlapping Determinants on Glutamic Acid Decarboxylase and Use Distinct V{{beta}} Genes J. Immunol., March 1, 2001; 166(5): 2982 - 2991. [Abstract] [Full Text] [PDF]

				V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice J. Immunol., January 15, 2001; 166(2): 908 - 917. [Abstract] [Full Text] [PDF]

				S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes J. Immunol., December 15, 2000; 165(12): 6748 - 6755. [Abstract] [Full Text] [PDF]

				S. Winer, L. Gunaratnam, I. Astsatourov, R. K. Cheung, V. Kubiak, W. Karges, D. Hammond-McKibben, R. Gaedigk, D. Graziano, M. Trucco, et al. Peptide Dose, MHC Affinity, and Target Self-Antigen Expression Are Critical for Effective Immunotherapy of Nonobese Diabetic Mouse Prediabetes J. Immunol., October 1, 2000; 165(7): 4086 - 4094. [Abstract] [Full Text] [PDF]

				L. Geng, M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease PNAS, August 18, 1998; 95(17): 10055 - 10060. [Abstract] [Full Text] [PDF]

				J. Salaun, N. Simmenauer, P. Belo, A. Coutinho, and N. M. Le Douarin Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes PNAS, January 22, 2002; 99(2): 874 - 877. [Abstract] [Full Text] [PDF]